Research from Redeye, Redeye AB

Redeye

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen). 

Expertise in Denmark, Finland, Norway and Sweden.

Research from Redeye

Redeye AB

Specialists in innovative and fast-growing Nordic companies within Life Science and Technology.

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen).

Equity Bottom-Up

<ul><li>Redeye leaves a comment following OncoZenge’s announcement of conditional acceptance of its Clinical Trial Application (CTA) for the pivotal Phase III study of BupiZenge in Europe.</li><li>We are encouraged to see that the company has successfully addressed regulatory questions and progressed the application to near-final approval, marking an important step as OncoZenge transitions from preparation to execution of its registrational trial.</li></ul>

Redeye leaves a comment following OncoZenge’s announcement of conditional acceptance of its Clinical Trial Application (CTA) for the pivotal Phase III study of BupiZenge in Europe.We are encouraged to see that the company has successfully addressed regulatory questions and progressed the application to near-final approval, marking an important step as OncoZenge transitions from preparation to execution of its registrational trial.

OncoZenge: Conditional acceptance for Phase III trial

Oncozenge

OncoZenge: Conditional acceptance for Phase III trial